返回 Agenda
Session 5B: Health Canada Policy Activities and Transparency Updates
Session Chair(s)
Karen Feltmate
President, Redstone Health Group, Inc., Canada
This session provides an opportunity for Health Canada to provide an update on key policy and regulatory activities. The department has a number of priorities which fall under its mandate, a few of which were discussed by senior government officials during the opening plenaries. This session delves deeper into additional policy and regulatory issues being led by the department. Leaders within the Health Products and Food Branch will provide timely updates on these initiatives, including outlining the policy objectives, the specific actions being implemented, and the applicable timelines. Whether you are in academia, industry, a not-for-profit, or a regulator, this information will help build your overall knowledge of issues affecting your work and the broader Canadian population as a whole.
Speaker(s)
Laura Johnson
Project Manager, Health Canada, Canada
Update on Premarket Transparency Initiatives for Drugs and Medical Devices
Lucye Galand, DVM, MBA, MSC
Acting Director, BGIVD, Therapeutic Products Directorate, HPFB, Health Canada, Canada
Anti-Microbial Resistance: An Overview of Health Canada's Activities
Celia Lourenco, PHD
Director General, Biologic and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada, Canada
Regulatory Foresight: Anticipating the Health Needs of Canadians
Elizabeth Toller, MA
Associate Director General, Policy, Planning and International Affairs Directora, Health Canada, Canada